It was demonstrated in animal studies that ANXA1 could alleviate the disease severity of various autoimmune diseases, including inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) (17, 18). Here, ANXA1 is linked to rheumatoid arthritis.